Aimei Health Technology, a blank check company targeting small-cap healthcare businesses, raised the proposed deal size for its upcoming IPO on Friday.
The New York, NY-based company now plans to raise $60 million by offering 6 million units at $10. The company had previously filed to offer 5 million units at the same price. Each unit consists of one share of common stock and one right to receive one-fifth of a share upon the completion of an initial business combination. At the revised terms, Aimei Health Technology will raise 20% more in proceeds than previously anticipated.
The company is led by CEO and Director Juan Fernandez, the former General Manager of Chassis Brakes International Spain, and CFO and Director Heung Ming Wong, the former CFO of publicly-traded companies Meten EdtechX (now Meten Holding Group) and Frontier Services Group.
The SPAC plans to target small-cap companies in North America, Europe, and the Asia Pacific regions that are developing assets in the biopharmaceutical, medical technology/medical device, and diagnostics spaces. It does not plan to target businesses in China (incl. Hong Kong and Macau).
Aimei Health Technology was founded in 2023 and plans to list on the Nasdaq under the symbol AFJKU. Spartan Capital Securities is the sole bookrunner on the deal.
